https://www.selleckchem.com/products/Eloxatin.html
S in the follow-up. AngioJet thrombectomy has stronger clearance ability for acute lower extremity deep venous thrombosis leading to significant reduction in the consumption of hospital resources, total dose of thrombolytic agents, and infusion time, thereby preventing adverse bleeding events, but patients with renal insufficiency should be careful. Ideal short-term and medium-term efficacy and safety are certain. AngioJet thrombectomy has stronger clearance ability for acute lower extremity deep venous thrombosis leading to significan